Share this post on:

Product Name :
WS-383

Search keywords :
WS-383

drugId :
null

Target Vo:
NEDD8-conjugating enzyme Ubc12

Target Vo Short Name :
UBE2M

Moa_Name:
DCN1 and UBC12 interaction inhibitor

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Zhengzhou University

Active Company_Name :
University Of Michigan

Active Indication_Name:

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:
Preclinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
SRC1 Rabbit mAb MedChemExpress
Cosibelimab manufacturer
IL-6 Antibody (YA724): IL-6 Antibody (YA724) is a non-conjugated and Mouse origined monoclonal antibody about 24 kDa, targeting to IL-6. It can be used for WB,IHC-P,ICC,ELISA assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Interleukin Related